Scaling Smiles: Inside Smile Doctors' Strategy for Market Dominance

DALLAS, TX – July 21, 2026

In a decisive move that signals a new era of strategic expansion, Smile Doctors, the nation's largest ortho-focused support organization (OSO), has appointed Jeff Knudson as its new chief financial officer. This is far more than a routine C-suite appointment; it's the placement of a seasoned financial architect at the helm of a company navigating explosive growth in a market projected to swell from $22 billion in 2025 to nearly $27 billion by 2030. As Smile Doctors races to solidify its leadership, Knudson's arrival is a clear indicator that the organization is meticulously preparing to scale its operations, manage significant capital, and define the future of orthodontic care delivery in the United States.

The Architect for a Multi-Billion Dollar Market

Jeff Knudson is not a newcomer to the complexities of scaling large, multi-site healthcare enterprises. His resume reads like a blueprint for the exact challenges and opportunities facing Smile Doctors. Most recently, he served as CFO for the National Veterinary Associates (NVA) Group, another sprawling network of care providers. Before that, he spent three years as CFO of publicly traded AMN Healthcare (NYSE: AMN), a leader in healthcare staffing, where he was credited with guiding the company through volatile market conditions. His experience extends to senior finance roles at giants like CVS Health, where he was the finance lead for its $80 billion retail pharmacy segment. This deep expertise in building financial discipline and robust operational capabilities is precisely what a rapidly expanding platform like Smile Doctors requires.

"Jeff brings the strategic perspective we need to lead the business through its next phase," said J. Hedrick, chief executive officer of Smile Doctors, in the company's announcement. "His leadership will be critical as we continue expanding our platform, investing in our affiliated practices and strengthening the foundation for what comes next."

Knudson himself seems keenly aware of the delicate balance required in such a role. He acknowledges the potential for growth to dilute quality if not managed thoughtfully. "Healthcare organizations have an opportunity to grow in ways that strengthen—not dilute—the patient experience," Knudson stated. "The finance function plays an important role in making that possible by helping organizations invest thoughtfully, allocate capital responsibly and build the capabilities that allow doctors and care teams to focus on what matters most: delivering exceptional care for every patient." This philosophy will be put to the test as Smile Doctors pushes past 591 affiliated locations toward its goal of 600 by the end of 2026.

The Rise of the Ortho-Support Organization

Smile Doctors’ rapid ascent is powered by the Ortho-focused Support Organization (OSO) model, an innovation that is fundamentally transforming the business of specialized dental care. Unlike a traditional private practice where orthodontists juggle clinical duties with the burdens of marketing, HR, billing, and IT, the OSO model centralizes these administrative functions. Smile Doctors provides its network of affiliated practices with sophisticated tools, technology, and back-office support, theoretically freeing clinicians to dedicate their full attention to patient outcomes.

This model is a key driver of consolidation within the fragmented orthodontic market. It allows for economies of scale, greater purchasing power for supplies and technology, and unified branding that can outmatch smaller, independent offices. While the broader dental industry has large Dental Support Organizations (DSOs) like Heartland Dental and Aspen Dental, Smile Doctors' competitive edge lies in its specialized focus. By dedicating its resources exclusively to orthodontics, it can offer tailored support and technology that resonate deeply with practitioners in that field, making it an attractive partner for orthodontists looking to shed administrative weight without sacrificing their professional focus.

The model's success is evident in the company's performance. Smile Doctors reported double-digit revenue growth in the first half of 2026, a result attributed to strong performance at existing stores, the addition of new orthodontist affiliations, and a growing demand from adults seeking treatment through platforms like Smile Express® powered by Invisalign®.

Capital and Technology: Fueling the Expansion Engine

Ambitious growth requires significant fuel, and Smile Doctors has secured it. During the second quarter of 2026, the organization locked in an additional $125 million in growth capital. This infusion is not for maintaining the status quo; it is earmarked for aggressive expansion. The company plans to open 18 additional locations over the next 12 months, pursuing a multi-pronged strategy that balances acquisitions with organic growth.

This expansion includes bringing existing, established practices into its network through new affiliations, which provides immediate market presence and revenue. Simultaneously, the company is pursuing 'de novo' openings—building new clinics from the ground up. This approach allows Smile Doctors to embed its technology, branding, and patient experience protocols from day one. Technology is a cornerstone of this strategy. The increasing demand from adults, a demographic once hesitant to pursue orthodontics, is being captured through convenient and discreet solutions like clear aligners, promoted via platforms such as Smile Express®. This focus on technological innovation not only widens the potential patient pool but also positions Smile Doctors at the forefront of a modernizing industry.

Balancing Scale with the Standard of Care

With rapid, private equity-fueled growth comes a critical question: can an organization focused on scaling and financial returns maintain the high standard of patient care and doctor autonomy that defines clinical excellence? This is the central challenge for Smile Doctors and the OSO model at large. Critics of corporate healthcare consolidation often raise concerns about the potential for standardization to erode personalized care, or for financial targets to influence clinical decisions.

Smile Doctors' leadership appears to be proactively addressing this tension. The company's mission explicitly states its goal is to "create confident smiles that inspire the best in patients, each other, and the communities they serve." Knudson’s public commitment to strengthening the patient experience through growth serves as a direct acknowledgment of this core challenge. The strategy appears to be one of empowerment, not control. By providing affiliated orthodontists with superior technology, operational support, and continuing education resources, the organization aims to elevate, rather than diminish, their ability to provide exceptional care.

The ultimate success of Smile Doctors' ambitious strategy will be measured on two fronts: its financial performance and its ability to consistently deliver positive patient outcomes across a vast and growing network. With Jeff Knudson managing the financial architecture, the company is poised for significant expansion. His true test, however, will be proving that in the modern world of healthcare, scale and quality are not mutually exclusive but can be powerful, synergistic forces that redefine an entire industry.